Supriya Lifescience and KIIT develop Quickblue oral cancer detection kit
Mumbai’s Supriya Lifescience Ltd, a recognized active pharmaceutical ingredients (API) manufacturer, in alliance with Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, introduces a revolutionary oral cancer detection tool: the Quickblue oral kit. This invention aims to detect oral cancer economically and efficiently, potentially reducing extensive preclinical and clinical trials. The patent for this kit has already been filed by Supriya Lifescience.
The Potential Impact of Quickblue on Oral Cancer Detection
Dr. Satish Wagh, Chairman of Supriya Lifescience Ltd, suggests that the Quickblue oral kit can notably lower oral cancer detection expenses, potentially eliminating the need for several biopsies in cases of non-healing oral ulcers. He stated, “The high prevalence of oral cancer, with millions of cases reported globally, underscores the importance of early detection. This product is particularly relevant in India and the Asian subcontinent, where a significant percentage of oral cancer patients are found.”
According to Dr. Wagh, early detection is pivotal for enhanced treatment results, and the Quickblue oral kit plays a critical role by recognizing oral cancer at its nascent stage. He emphasized, “The development of the Quickblue oral kit is a promising advancement in the healthcare sector. It makes oral cancer detection more accessible, economical, and lifesaving, highlighting the significance of innovation in the pharmaceutical and healthcare domain.”
Speaking of the company’s vision, Dr. Wagh added, “This initiative aligns with Supriya Lifescience’s ambition of producing niche items addressing unmet medical necessities. We are progressing towards diversifying our product range and envisage a significant expansion in the forthcoming decade.”
KIIT’s Research Contribution to Quickblue’s Development
Dr. Mrutyunjay Suar, Director General R&D and Innovation at KIIT University, conveyed his pride in collaborating with Supriya Lifescience for this innovative product. He mentioned, “KIIT is dedicated to supreme research quality and offers top-notch facilities for our academic community. Our extensive research spectrum encompasses biotechnology, medicine, and various other fields. Our scholar and faculty groups have diligently collaborated with Supriya Lifescience’s team in this endeavor. We firmly believe in this product’s potential as an early oral cancer detection lifesaver.”